Peptides are rapidly emerging as one of the most discussed frontiers in modern medicine and longevity science. Yet alongside the promise sits significant confusion, misinformation and regulatory complexity. Understanding where peptides genuinely fit within evidence-based healthcare is becoming increasingly important for clinicians, entrepreneurs and high-performing professionals seeking better health outcomes.

 

That’s where Paloma Hatami comes in. She is a multidisciplinary entrepreneur with degrees in arts, commerce and law, she also holds advanced qualifications in nutrigenomics and medical genetics, including studies through Stanford University. She has founded and exited multiple ventures, including Oscar & Wilde, and now leads several health-focused companies including Actionable Genomics, MyGene, Therapeptics and Therapath Medical. 

She discusses peptide therapy, the difference between clinical medicine and biohacking trends, the importance of pharmaceutical-grade manufacturing, and where peptides may legitimately support health span, recovery and modern longevity strategies. 

Takeaways 
Peptides may shape medicine’s future, but misinformation is spreading just as fast. 
Evidence, regulation and medical supervision matter far more than online hype. 
Not all peptides are equal, and quality control is critical. 
Biohacking trends often spotlight therapies before science fully catches up. 
Peptides can support recovery, but they are not magic fixes. 
Lifestyle, nutrition and sleep still form the foundation of health. 
Illegal imports and grey-market products carry serious risks and unknowns. 
The real opportunity lies in careful, ethical, evidence-based clinical application. 

Follow Polama Hatami 
https://therapath.com.au/ 
https://mygene.com.au/ 

Books recommended 
We'll Prescribe You a Cat: The feel good Japanese bestselling book https://amzn.to/4b6Rwlw 

Watch the episode on YouTube: https://www.youtube.com/@TheEvolutionPartners 

Newsletter – each week I share interesting insights, articles and ideas you can use. Join other leaders and subscribe to The Evolution Partners newsletter https://evolutionpartners.com.au/subscribe/ 

Books – Learn more about our books https://evolutionpartners.com.au/books/
Made to Thrive: The practical, prescriptive guide on how to be a great CEO 
Onboarded: How to bring new hires to the points where they are more effective faster. A business case for leaders on why you should commit to an effective onboarded process. 
Onboarded for Managers: Helping managers bring new hires to the point where they are more effective faster. 
Bigger isn’t Better, Better is Better: Avoiding the pressure of endless growth to build a better business (and better life) 

Follow me: 
on https://au.linkedin.com/in/bradleygiles  
on https://twitter.com/Evolution_Perth 

Enjoying the show? Leave a review 

Peptides are rapidly emerging as one of the most discussed frontiers in modern medicine and longevity science. Yet alongside the promise sits significant confusion, misinformation and regulatory complexity. Understanding where peptides genuinely fit within evidence-based healthcare is becoming increasingly important for clinicians, entrepreneurs and high-performing professionals seeking better health outcomes.
&nbsp;
That&rsquo;s where Paloma Hatami comes in. She is a multidisciplinary entrepreneur with degrees in arts, commerce and law, she also holds advanced qualifications in nutrigenomics and medical genetics, including studies through Stanford University. She has founded and exited multiple ventures, including Oscar &amp; Wilde, and now leads several health-focused companies including Actionable Genomics, MyGene, Therapeptics and Therapath Medical.&nbsp;
She discusses peptide therapy, the difference between clinical medicine and biohacking trends, the importance of pharmaceutical-grade manufacturing, and where peptides may legitimately support health span, recovery and modern longevity strategies.&nbsp;
Takeaways&nbsp;
<ul>
<li>Peptides may shape medicine&rsquo;s future, but misinformation is spreading just as fast.&nbsp;</li>
<li>Evidence, regulation and medical supervision matter far more than online hype.&nbsp;</li>
<li>Not all peptides are equal, and quality control is critical.&nbsp;</li>
<li>Biohacking trends often spotlight therapies before science fully catches up.&nbsp;</li>
<li>Peptides can support recovery, but they are not magic fixes.&nbsp;</li>
<li>Lifestyle, nutrition and sleep still form the foundation of health.&nbsp;</li>
<li>Illegal imports and grey-market products carry serious risks and unknowns.&nbsp;</li>
<li>The real opportunity lies in careful, ethical, evidence-based clinical application.&nbsp;</li>
</ul>
Follow Polama Hatami <a href="https://therapath.com.au/">https://therapath.com.au/</a>&nbsp; <a href="https://mygene.com.au/">https://mygene.com.au/</a>&nbsp;
Books recommended We'll Prescribe You a Cat: The feel good Japanese bestselling book <a href="https://amzn.to/4b6Rwlw">https://amzn.to/4b6Rwlw</a>&nbsp;
Watch the episode on YouTube: <a href="https://www.youtube.com/@TheEvolutionPartners">https://www.youtube.com/@TheEvolutionPartners</a>&nbsp;
Newsletter &ndash; each week I share interesting insights, articles and ideas you can use. Join other leaders and subscribe to The Evolution Partners newsletter <a href="https://evolutionpartners.com.au/subscribe/">https://evolutionpartners.com.au/subscribe/</a>&nbsp;
Books &ndash; Learn more about our books&nbsp;<a href="https://evolutionpartners.com.au/books/">https://evolutionpartners.com.au/books/</a> <a href="https://evolutionpartners.com.au/made-to-thrive/"> Made to Thrive:</a>&nbsp;The practical, prescriptive guide on how to be a great CEO <a href="https://evolutionpartners.com.au/onboarded/">Onboarded:&nbsp;</a>How to bring new hires to the points where they are more effective faster. A business case for leaders on why you should commit to an effective onboarded process. <a href="https://evolutionpartners.com.au/onboarded-for-managers-book/">Onboarded for Managers:</a>&nbsp;Helping managers bring new hires to the point where they are more effective faster. <a href="https://evolutionpartners.com.au/bigger-isnt-better/">Bigger isn&rsquo;t Better, Better is Better:</a>&nbsp;Avoiding the pressure of endless growth to build a better business (and better life)&nbsp;
Follow me: on <a href="https://au.linkedin.com/in/bradleygiles">https://au.linkedin.com/in/bradleygiles</a>&nbsp; on <a href="https://twitter.com/Evolution_Perth">https://twitter.com/Evolution_Perth</a>&nbsp;
Enjoying the show? Leave a review&nbsp;

A place for the world’s leading thinkers, planners and doers.

The Evolution Partners is a weekly podcast hosted by Brad Giles. Join Brad as he engages in conversations with some of the world’s sharpest minds, learning a bit more about them and delving into what makes them tick.

A place for the world’s leading thinkers, planners and doers.
The Evolution Partners is a weekly podcast hosted by Brad Giles. Join Brad as he engages in conversations with some of the world’s sharpest minds, learning a bit more about them and delving into what makes them tick.

The Evolution Partners

Each week Brad Giles talks with the world’s leading thinkers, planners and doers who are helping to build great companies in their own way.

We learn how the work they’re doing is creating an impact and get to know a little bit more about them, and what makes them tick.

Each week Brad Giles talks with the world’s leading thinkers, planners and doers who are helping to build great companies in their own way.
We learn how the work they’re doing is creating an impact and get to know a little bit more about them, and what makes them tick.